Charles River Laboratories International (CRL) Return on Sales [ROS] (2009 - 2026)
Charles River Laboratories International's Return on Sales [ROS] was 11.94% in Q2 2026, up 2.24 percentage points from 9.70% a year earlier but down 0.10 percentage points from the prior quarter.
Charles River Laboratories International (CRL) Return on Sales [ROS] (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Charles River Laboratories International's Return on Sales [ROS] was 2.25% through Jun 27, 2026, down 0.84 percentage points year-over-year; for FY2025, it was 0.63%, down 4.99 percentage points from FY2024.
- Return on Sales [ROS] has now declined for four consecutive years, with a five-year change of -14.17 percentage points (FY2020 to FY2025).
- In earlier years, Return on Sales [ROS] was 5.61% in FY2024 (-9.33 pp), 14.95% in FY2023 (-1.42 pp), 16.37% in FY2022 (-0.29 pp) and 16.66% in FY2021 (+1.86 pp).
- Quarterly Return on Sales [ROS] has moved between -28.51% (Q4 2025) and 19.26% (Q2 2022) over five years.
- Compared with a year earlier, Return on Sales [ROS] was higher in three of the last eight quarters, with an average year-over-year change of -5.79 percentage points.
- The best year-over-year quarter for Return on Sales [ROS] over five years was Q1 2026 (a gain of 4.45 percentage points); the worst was Q4 2024 (a drop of 29.84 percentage points).
- Per Business Quant data, CRL's Return on Sales [ROS] in the three quarters before Q2 2026 was 12.04% (Q1 2026), -28.51% (Q4 2025) and 13.32% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 43.59 Bn | 35.30 Bn | 1.44 Bn | 11.58% |
| 2 | Medpace Holdings | 17.35 Bn | 15.41 Bn | 201.64 Mn | 20.76% |
| 3 | Charles River Laboratories International | 14.57 Bn | 13.77 Bn | 363.37 Mn | 11.94% |
| 4 | Icon | 13.15 Bn | 10.26 Bn | 479.29 Mn | 6.68% |
| 5 | Fortrea Holdings | 2.02 Bn | 1.40 Bn | 139.20 Mn | 2.18% |
| 6 | Ginkgo Bioworks Holdings | 720.92 Mn | -41.17 Mn | 18.44 Mn | -290.47% |
| 7 | Evotec SE | 502.55 Mn | -1.11 Bn | - | - |
| 8 | Champions Oncology | 66.57 Mn | 41.65 Mn | 7.70 Mn | -2.69% |
| 9 | MindWalk Holdings | 63.08 Mn | 26.73 Mn | 1.61 Mn | -159.86% |
| 10 | Natural Alternatives International | 6.81 Mn | -21.27 Mn | 1.73 Mn | -38.18% |
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 11.94% |
| Mar 28, 2026 | 12.04% |
| Dec 27, 2025 | -28.51% |
| Sep 27, 2025 | 13.32% |
| Jun 28, 2025 | 9.70% |
| Mar 29, 2025 | 7.59% |
| Dec 28, 2024 | -16.73% |
| Sep 28, 2024 | 11.63% |
| Jun 29, 2024 | 14.78% |
| Mar 30, 2024 | 12.45% |
| Dec 30, 2023 | 13.12% |
| Sep 30, 2023 | 14.76% |
| Jul 1, 2023 | 15.56% |
| Apr 1, 2023 | 16.31% |
| Dec 31, 2022 | 14.89% |
| Sep 24, 2022 | 15.26% |
| Jun 25, 2022 | 19.26% |
| Mar 26, 2022 | 16.28% |
| Dec 25, 2021 | 19.09% |
| Sep 25, 2021 | 17.39% |
Charles River Laboratories International Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CRL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "CRL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CRL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();